1. Home
  2. GDTC vs BTCM Comparison

GDTC vs BTCM Comparison

Compare GDTC & BTCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • BTCM
  • Stock Information
  • Founded
  • GDTC 2018
  • BTCM 2001
  • Country
  • GDTC Singapore
  • BTCM United States
  • Employees
  • GDTC N/A
  • BTCM N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • BTCM EDP Services
  • Sector
  • GDTC Health Care
  • BTCM Technology
  • Exchange
  • GDTC Nasdaq
  • BTCM Nasdaq
  • Market Cap
  • GDTC 21.5M
  • BTCM 50.1M
  • IPO Year
  • GDTC 2023
  • BTCM 2013
  • Fundamental
  • Price
  • GDTC $1.89
  • BTCM $2.56
  • Analyst Decision
  • GDTC Buy
  • BTCM Hold
  • Analyst Count
  • GDTC 1
  • BTCM 1
  • Target Price
  • GDTC $5.00
  • BTCM N/A
  • AVG Volume (30 Days)
  • GDTC 18.1K
  • BTCM 10.1M
  • Earning Date
  • GDTC 01-01-0001
  • BTCM 08-05-2025
  • Dividend Yield
  • GDTC N/A
  • BTCM N/A
  • EPS Growth
  • GDTC N/A
  • BTCM N/A
  • EPS
  • GDTC N/A
  • BTCM 0.62
  • Revenue
  • GDTC $368,838.00
  • BTCM $32,921,999.00
  • Revenue This Year
  • GDTC $5.37
  • BTCM $14.32
  • Revenue Next Year
  • GDTC N/A
  • BTCM N/A
  • P/E Ratio
  • GDTC N/A
  • BTCM $3.84
  • Revenue Growth
  • GDTC N/A
  • BTCM N/A
  • 52 Week Low
  • GDTC $1.20
  • BTCM $1.22
  • 52 Week High
  • GDTC $4.05
  • BTCM $8.07
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 37.08
  • BTCM 43.80
  • Support Level
  • GDTC $1.85
  • BTCM $2.75
  • Resistance Level
  • GDTC $1.95
  • BTCM $4.61
  • Average True Range (ATR)
  • GDTC 0.10
  • BTCM 0.53
  • MACD
  • GDTC -0.02
  • BTCM -0.21
  • Stochastic Oscillator
  • GDTC 28.00
  • BTCM 1.50

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About BTCM BIT Mining Limited ADS

BIT Mining Ltd is a cryptocurrency mining company, with a long-term plan to encompass the whole cryptocurrency value chain. Its business covers cryptocurrency mining, mining pool, data center operation and mining machine manufacturing. The company has a related and growing deployed Bitcoin mining machine capacity, owns three hydroelectric cryptocurrency mines with combined power capacity of 435MW and the entire mining pool business operated under BTC.com, including the domain name and wallet. It has also entered into a definitive agreement to acquire a 7 nanometer cryptocurrency mining machine manufacturer "Bee Computing", completing its vertical integration, making self-sufficient while also strengthening competitive position.

Share on Social Networks: